Title

T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell-Derived Experimental Glioblastomas

UMMS Affiliation

Department of Radiology

Date

6-1-2016

Document Type

Response or Comment

Disciplines

Neoplasms | Neurology | Radiology

Abstract

We read with great interest the article by Arevalo-Perez et al, describing the potential value of T1-weighted dynamic contrast-enhanced MR imaging (DCE-MR imaging) as a biomarker for epidermal growth factor receptor variant III (EGFRvIII) mutation in patients with glioblastoma (GBM).

Rights and Permissions

Citation: AJNR Am J Neuroradiol. 2016 Jun;37(6):E49-51. Mar 17. Link to article on publisher's site

Related Resources

Link to Article in PubMed

PubMed ID

26988813